Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Palese

Showing results (231-240 of 291) with videos related to

Pageof 30
Sort By:
Vaccine|April 16, 2024
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sexJose L Martínez, Nicholas Lemus, Tsoi Ying Lai, et al.
Lancet Regional Health. Americas|July 8, 2025
Enhancing the response to avian influenza in the US and globallyMaggie L Bartlett, Peter Palese, Meghan F Davis, et al.
NPJ Vaccines|November 17, 2024
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approachIrene González-Domínguez, Eduard Puente-Massaguer, Adam Abdeljawad, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccinesMitali Mishra, Eduard Puente-Massaguer, Andrew T Jones, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in miceCarly M Bliss, Alec W Freyn, Tom G Caniels, et al.
Ebiomedicine|May 28, 2024
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoproteinCarly M Bliss, Raffael Nachbagauer, Chiara Mariottini, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategiesArun K Kashyap, John Steel, Ahmet F Oner, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 virusesNatalie Pica, Rong Hai, Florian Krammer, et al.
Molecular Therapy. Nucleic Acids|April 24, 2026
Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in miceIrene González-Domínguez, Marta Boza, Adam Abdeljawad, et al.
The Journal of Infectious Diseases|January 3, 2025
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernVictoria Dolange, Stefan Slamanig, Adam Abdeljawad, et al.
Pageof 30

Showing results (231-240 of 291) with videos related to

Sort By:
Pageof 30
Vaccine|April 16, 2024
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sexJose L Martínez, Nicholas Lemus, Tsoi Ying Lai, et al.
Lancet Regional Health. Americas|July 8, 2025
Enhancing the response to avian influenza in the US and globallyMaggie L Bartlett, Peter Palese, Meghan F Davis, et al.
NPJ Vaccines|November 17, 2024
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approachIrene González-Domínguez, Eduard Puente-Massaguer, Adam Abdeljawad, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccinesMitali Mishra, Eduard Puente-Massaguer, Andrew T Jones, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in miceCarly M Bliss, Alec W Freyn, Tom G Caniels, et al.
Ebiomedicine|May 28, 2024
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoproteinCarly M Bliss, Raffael Nachbagauer, Chiara Mariottini, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategiesArun K Kashyap, John Steel, Ahmet F Oner, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 virusesNatalie Pica, Rong Hai, Florian Krammer, et al.
Molecular Therapy. Nucleic Acids|April 24, 2026
Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in miceIrene González-Domínguez, Marta Boza, Adam Abdeljawad, et al.
The Journal of Infectious Diseases|January 3, 2025
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernVictoria Dolange, Stefan Slamanig, Adam Abdeljawad, et al.
Pageof 30